CETP and Fabry disease: The lipoprotein profile in APOE*3Leiden.CETP mice reflects that of FD patients with a similar response to lipid-modifying therapies (30), including statins (31), fibrates (32), niacin (33), and cholesteryl ester transfer protein inhibitors (34).